Toshiba America Medical Systems has announced it has received FDA clearance for its ENCORE VeloCT console, according to a news release.
Features of the console include new enhancements for patient safety, dose management and workflow for existing Aquilion 32, Aquilion 64 and Aquilion CX CT systems, multiple dose reduction technologies and dose management tools, according to the company.
"VeloCT is an example of Toshiba's commitment to providing customers with advanced dose management tools and workflow solutions to make CT exams even safer," said Tim Nicholson, senior manager, market development, CT business unit for Toshiba, in the release. "VeloCT helps customers plan for the future by upgrading today’s existing technology to meet the healthcare needs of tomorrow."
Toshiba America Medical Systems is headquartered in Tustin, Calif.
Related Articles on FDA Clearances:
ETView Receives FDA 510(k) Clearance for Endobronchial Blocker
Mevion Medical Systems Receives FDA 510(k) Clearance for Proton Therapy System
Hansen Medical Receives FDA 510(k) Clearance for Peripheral Vascular Interventions System